BankPlus Trust Department Sells 117 Shares of The Allstate Corporation $ALL

BankPlus Trust Department cut its position in The Allstate Corporation (NYSE:ALL) by 8.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,210 shares of the insurance provider’s stock after selling 117 shares during the quarter. BankPlus Trust Department’s holdings in Allstate were worth $244,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Brighton Jones LLC increased its stake in shares of Allstate by 60.2% in the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock valued at $1,253,000 after buying an additional 2,443 shares during the period. Revolve Wealth Partners LLC acquired a new stake in shares of Allstate in the fourth quarter valued at about $231,000. Miracle Mile Advisors LLC increased its stake in shares of Allstate by 1.7% in the first quarter. Miracle Mile Advisors LLC now owns 3,777 shares of the insurance provider’s stock valued at $782,000 after buying an additional 63 shares during the period. OLD National Bancorp IN increased its stake in shares of Allstate by 70.4% in the first quarter. OLD National Bancorp IN now owns 4,875 shares of the insurance provider’s stock valued at $1,009,000 after buying an additional 2,014 shares during the period. Finally, Portside Wealth Group LLC grew its stake in Allstate by 8.4% during the first quarter. Portside Wealth Group LLC now owns 1,424 shares of the insurance provider’s stock worth $295,000 after purchasing an additional 110 shares during the period. 76.47% of the stock is currently owned by institutional investors.

Allstate Stock Performance

Shares of Allstate stock opened at $211.69 on Wednesday. The business’s fifty day simple moving average is $205.41 and its 200 day simple moving average is $201.05. The firm has a market capitalization of $55.78 billion, a P/E ratio of 9.95, a price-to-earnings-growth ratio of 0.81 and a beta of 0.38. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, topping analysts’ consensus estimates of $3.20 by $2.74. The business had revenue of $15.05 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.Allstate’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $1.61 earnings per share. As a group, analysts anticipate that The Allstate Corporation will post 18.74 EPS for the current year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th were given a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Friday, August 29th. Allstate’s dividend payout ratio (DPR) is currently 18.81%.

Wall Street Analyst Weigh In

Several research firms recently commented on ALL. Barclays reaffirmed an “underweight” rating and set a $198.00 target price (up previously from $188.00) on shares of Allstate in a research note on Thursday, July 31st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Allstate in a research note on Saturday, September 27th. BMO Capital Markets raised their price objective on Allstate from $230.00 to $235.00 and gave the company an “outperform” rating in a research note on Wednesday, August 20th. Raymond James Financial reissued a “strong-buy” rating and issued a $260.00 price objective (up previously from $250.00) on shares of Allstate in a research note on Monday, August 4th. Finally, Roth Capital set a $230.00 price objective on Allstate and gave the company a “buy” rating in a research note on Friday, September 26th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Allstate has a consensus rating of “Moderate Buy” and an average target price of $231.56.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.